Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00182936
Status:
COMPLETED
Last Update Posted:
2006-11-20
First Post:
2005-09-13
Brief Title:
A Trial to Reduce Delirium in Aged Post Acute Patients
Sponsor:
National Institute on Aging NIA
Organization:
National Institute on Aging NIA
Study Overview
Official Title:
A Trial to Reduce Delirium in Aged Post Acute Patients
Status:
COMPLETED
Status Verified Date:
2006-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to develop a comprehensive Delirium Abatement Program of care of delirious patients in the post acute care setting and to evaluate its impact on persistence and severity of delirium and on functional recovery
Detailed Description:
Common morbid and costly delirium affects one third of hospitalized elders and plays a central role in the cascade of adverse events that leads to functional decline and loss of independence Moreover as acute care stays continue to shorten and evidence mounts that delirium may persist for many weeks concern about delirium can no longer be confined to the hospital It is believed that a Delirium Abatement Program may significantly reduce the persistence of delirium in post-acute settings and thereby improve functional recovery both during the post-acute stay and after discharge
The Delirium Abatement Program DAP will be designed to assist facility staff to 1 detect delirium among new admissions 2 evaluate common underlying causes of delirium 3 prevent complications commonly associated with delirium and 4 restore delirious patients cognitive behavioral social and self care functioning to baseline status
This three year trial will enroll 500 delirious patients admitted to eight Boston area post-acute skilled nursing facilities The DAP intervention will be carried out in four facilities Four other facilities matched to the intervention by demographic facility and clinical characteristics will serve as controls Patients will be recruited within 72 hours maximum 120 hrs of admission assessed weekly while in the facility and at one three and six months following admission
The Delirium Abatement Program DAP will be designed to assist facility staff to 1 detect delirium among new admissions 2 evaluate common underlying causes of delirium 3 prevent complications commonly associated with delirium and 4 restore delirious patients cognitive behavioral social and self care functioning to baseline status
This three year trial will enroll 500 delirious patients admitted to eight Boston area post-acute skilled nursing facilities The DAP intervention will be carried out in four facilities Four other facilities matched to the intervention by demographic facility and clinical characteristics will serve as controls Patients will be recruited within 72 hours maximum 120 hrs of admission assessed weekly while in the facility and at one three and six months following admission
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| AG17649 | None | None | None |